Literature DB >> 16285609

Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.

Hiroshi Kajiwara1, Masanori Yasuda, Nobue Kumaki, Taro Shibayama, Yoshiyuki Osamura.   

Abstract

Carbohydrate antigens and E-selectin play important roles in the invasion and metastasis of cancers. We examined the expression of these antigens and their ligand protein, E-selectin, in urothelial carcinomas to evaluate whether their staining is correlated with the grade and stage of cancer. We studied the expression of carbohydrate antigens (type 1 and type 2 blood-group antigens) and E-selectin in urothelial carcinomas of the renal pelvis, ureter, and urinary bladder in 52 patients by staining SSEA-1 (LeX), sialyl LeX (sLeX), DU-PAN-2, CA19-9, and E-selectin with 5 different monoclonal antibodies (MAbs) to evaluate whether their staining correlated with cancer grade and stage. The differences between organs with regard to the degree of expression of these antigens were not evident. Type 2 antigens (SSEA-1 and sialyl LeX) are frequently expressed in the tumor cells regardless of atypical grade. The expression level of type 1 antigens (DU-PAN-2 and CA19-9) is lower than that of type 2 antigens. However, the presence of DU-PAN-2 tends to correlate with the grade of atypia; however, that of CA19-9 is inversely proportional to the grade of atypia. The lack of CA19-9 and appearance of DU-PAN-2 in urothelial carcinoma implies a high malignant potential. The expression of E-selectin can be correlated with stage and grade of tumor atypia. Type 2 antigen and E-selectin may be involved in tumor invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285609

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  13 in total

Review 1.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

Review 2.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

3.  Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?

Authors:  Monica M Burdick; Karissa A Henson; Luis F Delgadillo; Young Eun Choi; Douglas J Goetz; David F J Tees; Fabian Benencia
Journal:  Front Oncol       Date:  2012-08-20       Impact factor: 6.244

4.  A step towards refining prognostication in individual patients with bladder cancer.

Authors:  Muhammed Mubarak
Journal:  Urol Ann       Date:  2013-04

5.  CD10 and CA19.9 immunohistochemical expression in transitional cell carcinoma of the urinary bladder.

Authors:  Ahmed Salahaldeen Mohammed; Husam Hasson Ali; Ban Jumaa Qasim; Mohammed Kassim Chaloob
Journal:  Urol Ann       Date:  2013-04

6.  P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.

Authors:  Júlio Santos; Elisabete Fernandes; José Alexandre Ferreira; Luís Lima; Ana Tavares; Andreia Peixoto; Beatriz Parreira; José Manuel Correia da Costa; Paul J Brindley; Carlos Lopes; Lúcio L Santos
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

7.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

Review 8.  Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.

Authors:  Pradeep Tyagi; Mahendra P Kashyap; Naoki Kawamorita; Tsuyoshi Yoshizawa; Michael Chancellor; Naoki Yoshimura
Journal:  ISRN Pharmacol       Date:  2014-01-15

Review 9.  Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Bin Liang; Liansheng Zhong; Qun He; Shaocheng Wang; Zhongcheng Pan; Tianjiao Wang; Yujie Zhao
Journal:  Med Sci Monit       Date:  2015-11-18

10.  Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines.

Authors:  Bernadette Ezeabikwa; Nandini Mondal; Aristotelis Antonopoulos; Stuart M Haslam; Yasuyuki Matsumoto; Miguel Martin-Caraballo; Sylvain Lehoux; Msano Mandalasi; Ali Ishaque; Jamie Heimburg-Molinaro; Richard D Cummings; Anthony K Nyame
Journal:  Glycobiology       Date:  2021-12-18       Impact factor: 5.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.